HE Min, YU Hui-min, HUANG Xian-zhang. Angiotensin-Converting Enzyme 2, A Promising Therapeutic Target for Prevention of Hypertension[J]. Journal of Evidence-Based Medicine, 2014, 14(5): 313-316. DOI: 10.3969/j.issn.1671-5144.2014.05.020
    Citation: HE Min, YU Hui-min, HUANG Xian-zhang. Angiotensin-Converting Enzyme 2, A Promising Therapeutic Target for Prevention of Hypertension[J]. Journal of Evidence-Based Medicine, 2014, 14(5): 313-316. DOI: 10.3969/j.issn.1671-5144.2014.05.020

    Angiotensin-Converting Enzyme 2, A Promising Therapeutic Target for Prevention of Hypertension

    • Abstract: Angiotensin-converting enzyme 2 (ACE2) is a new component of the renin-angiotensin-aldosterone system (RAAS), which functions as a key enzyme in modulating blood pressure through metabolizing angiotensin Ⅱ(AngⅡ).The abnormal expression or catalytic activity of ACE2 may not only contribute to the development of hypertension, but also correlate with the curative effects of RAAS inhibitors.Based on these observations, ACE2 may be considered as a novel therapeutic tool for the treatment of cardiovascular diseases.This review summarizes the regulatory mechanism of ACE2, and discusses its therapeutic role for the prevention of hypertension.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return